Wednesday June 7th

William A. Cattrall

Department of Pharmacology, University of Washington, Seattle, USA

Bill Catterall received a B.A. in Chemistry from Brown University in 1968, a Ph.D. in Physiological Chemistry from Johns Hopkins in 1972, and postdoctoral training in neurobiology and molecular pharmacology as a Muscular Dystrophy Association Fellow with Dr. Marshall Nirenberg at the National Institutes of Health from 1972 to 1974. Following three years as a staff scientist at NIH, he joined the University of Washington in 1977 as Associate Professor of Pharmacology, became Professor in 1981, and served as Chair from 1984 to 2016. Catterall discovered the voltage-gated sodium and calcium channel proteins, which initiate electrical and chemical signaling in excitable cells. His work has contributed much to understanding their structure, function, regulation, molecular pharmacology, and roles in diseases. Catterall is a member of several science academies, including the US National Academy of Science, National Academy of Medicine, and the Royal Society of London, UK. He has received numerous awards, including the Gairdner International Award of Canada in 2010.

Life in the Fast Lane: Electric Signaling at Atomic Resolution

All rapid physiological processes are triggered by electrical signals, from swimming in Paramecium to athletics in man. Voltage-gated sodium channels initiate action potentials and voltage-gated calcium channels initiate contraction, secretion, neurotransmission, and more. Dysfunction of these channels causes epilepsy, cardiac arrhythmia, and chronic pain. Recent discovery of bacterial ancestors of sodium and calcium channels has allowed us to determine the structural basis for voltage-dependent activation, inactivation, and rapid, highly selective ion conductance at atomic resolution by X-ray crystallography. These channels are targets for drugs used for pain, epilepsy, arrhythmia, hypertension, and angina. The receptor sites for these drugs are now being elucidated at atomic resolution, with important implications for structure-based drug design.

Read more about William A. Catteralls research here

Host: Misty Marshall

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Ok!Read More
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.